output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Depression [*therapy]; 2. Electric Stimulation Therapy [*methods]; | Provide MESH terms for the study
Alternating current cranial electrotherapy stimulation (CES) for depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐1 Receptor Antagonists [therapeutic use]; 2. Amines [therapeutic use]; 3. Anti‐Anxiety Agents [therapeutic use]; 4. Anti‐Inflammatory Agents [therapeutic use]; 5. Antidepressive Agents, Second‐Generation [therapeutic use]; 6. Citalopram [therapeutic use]; 7. Cyclohexanecarboxylic Acids [therapeutic use]; 8. Gabapentin; 9. Hydrocortisone [therapeutic use]; 10. Propranolol [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Stress Disorders, Post‐Traumatic [*prevention & control]; 13. Temazepam [therapeutic use]; 14. gamma‐Aminobutyric Acid [therapeutic use]; | Provide MESH terms for the study
Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD) | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [administration & dosage, therapeutic use]; 2. Delayed‐Action Preparations [administration & dosage, therapeutic use]; 3. Flupenthixol [administration & dosage, *analogs & derivatives, therapeutic use]; 4. Psychotic Disorders [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Schizophrenia [*drug therapy]; 7. Tranquilizing Agents [administration & dosage, *therapeutic use]; | Provide MESH terms for the study
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders | You are a research assistant. Based on the question please provide appropriate answers |
1. Akathisia, Drug‐Induced; 2. Antipsychotic Agents [adverse effects, *therapeutic use]; 3. Phenothiazines [adverse effects, *therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Schizophrenia [*drug therapy]; 6. Spasm [chemically induced]; 7. Tremor [chemically induced]; | Provide MESH terms for the study
Pericyazine for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antimanic Agents [*therapeutic use]; 2. Antipsychotic Agents [*therapeutic use]; 3. Carbamazepine [*therapeutic use]; 4. Combined Modality Therapy [methods]; 5. Randomized Controlled Trials as Topic; 6. Recurrence; 7. Schizophrenia [*drug therapy]; | Provide MESH terms for the study
Carbamazepine for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Anesthetics, Intravenous [*administration & dosage]; 2. Depression [*therapy]; 3. Electroconvulsive Therapy [*adverse effects]; 4. Epilepsy, Tonic‐Clonic [*complications]; 5. Etomidate [administration & dosage]; 6. Hypnotics and Sedatives [*administration & dosage]; 7. Methohexital [administration & dosage]; 8. Midazolam [administration & dosage]; 9. Propofol [administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Thiamylal [administration & dosage]; 12. Thiopental [administration & dosage]; | Provide MESH terms for the study
Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [*therapeutic use]; 2. Placebos [therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Schizophrenia [*drug therapy]; 5. Sulpiride [*therapeutic use]; | Provide MESH terms for the study
Sulpiride versus placebo for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Health Status; 2. *Quality of Life; 3. Awareness; 4. Health Behavior; 5. Health Promotion [*methods]; 6. Mental Disorders [*complications, mortality]; 7. Randomized Controlled Trials as Topic; 8. Standard of Care; | Provide MESH terms for the study
General physical health advice for people with serious mental illness | You are a research assistant. Based on the question please provide appropriate answers |
1. Alzheimer Disease [*drug therapy]; 2. Amyloid beta‐Peptides [metabolism]; 3. Chelating Agents [adverse effects, *therapeutic use]; 4. Clioquinol [adverse effects, analogs & derivatives, *therapeutic use]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Metal protein attenuating compounds for the treatment of Alzheimer's dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Health Status; 2. *Quality of Life; 3. Disease Progression; 4. Mental Disorders [*complications]; | Provide MESH terms for the study
Physical health care monitoring for people with serious mental illness | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers [*psychology]; 2. Dementia [*nursing, psychology]; 3. Randomized Controlled Trials as Topic; 4. Respite Care [*psychology]; 5. Stress, Psychological [*therapy]; 6. Therapeutic Touch; | Provide MESH terms for the study
Respite care for people with dementia and their carers | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [adverse effects, *therapeutic use]; 2. Perazine [adverse effects, *therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Schizophrenia [*drug therapy]; | Provide MESH terms for the study
Perazine for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [adverse effects, *therapeutic use]; 2. Chlorpromazine [adverse effects, *therapeutic use]; 3. Placebo Effect; 4. Randomized Controlled Trials as Topic; 5. Schizophrenia [*drug therapy, prevention & control]; 6. Secondary Prevention; | Provide MESH terms for the study
Chlorpromazine versus placebo for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [*therapeutic use]; 2. Aripiprazole; 3. Benzodiazepines [therapeutic use]; 4. Piperazines [*therapeutic use]; 5. Quinolones [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Schizophrenia [*drug therapy]; | Provide MESH terms for the study
Aripiprazole versus other atypical antipsychotics for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [*adverse effects]; 2. Cholinergic Antagonists [*therapeutic use]; 3. Schizophrenia [*drug therapy]; 4. Sialorrhea [chemically induced, *drug therapy]; | Provide MESH terms for the study
Anticholinergic medication for non‐clozapine neuroleptic‐induced hypersalivation in people with schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetamides [adverse effects, *therapeutic use]; 2. Antidepressive Agents [adverse effects, *therapeutic use]; 3. Depressive Disorder, Major [*drug therapy]; 4. Melatonin [agonists]; 5. Randomized Controlled Trials as Topic; 6. Selective Serotonin Reuptake Inhibitors [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Agomelatine versus other antidepressive agents for major depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [adverse effects, *therapeutic use]; 2. Benzodiazepines [adverse effects, therapeutic use]; 3. Clozapine [adverse effects, therapeutic use]; 4. Dibenzothiazepines [adverse effects, *therapeutic use]; 5. Medication Adherence [statistics & numerical data]; 6. Olanzapine; 7. Piperazines [adverse effects, therapeutic use]; 8. Quetiapine Fumarate; 9. Randomized Controlled Trials as Topic; 10. Risperidone [adverse effects, therapeutic use]; 11. Schizophrenia [*drug therapy]; 12. Thiazoles [adverse effects, therapeutic use]; | Provide MESH terms for the study
Quetiapine versus other atypical antipsychotics for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Akathisia, Drug‐Induced [etiology]; 2. Antipsychotic Agents [adverse effects, *therapeutic use]; 3. Dystonia [chemically induced]; 4. Haloperidol [adverse effects, *therapeutic use]; 5. Parkinsonian Disorders [chemically induced]; 6. Placebo Effect; 7. Randomized Controlled Trials as Topic; 8. Schizophrenia [*drug therapy]; 9. Treatment Outcome; | Provide MESH terms for the study
Haloperidol versus placebo for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [*therapeutic use]; 2. Delusions [drug therapy]; 3. Pimozide [*therapeutic use]; 4. Psychotic Disorders [*drug therapy, psychology]; 5. Randomized Controlled Trials as Topic; 6. Recurrence; 7. Schizophrenia [*drug therapy]; 8. Schizophrenic Psychology; | Provide MESH terms for the study
Pimozide for schizophrenia or related psychoses | You are a research assistant. Based on the question please provide appropriate answers |
1. *Dietary Supplements; 2. Depression, Postpartum [*prevention & control]; 3. Docosahexaenoic Acids [*administration & dosage]; 4. Eicosapentaenoic Acid [*administration & dosage]; 5. Patient Dropouts [statistics & numerical data]; 6. Prenatal Care; 7. Randomized Controlled Trials as Topic; 8. Selenium [*administration & dosage]; | Provide MESH terms for the study
Dietary supplements for preventing postnatal depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Antimanic Agents [*therapeutic use]; 2. Benzodiazepines [therapeutic use]; 3. Bipolar Disorder [*drug therapy, prevention & control]; 4. Drug Therapy, Combination [methods]; 5. Lithium Compounds [therapeutic use]; 6. Olanzapine; 7. Randomized Controlled Trials as Topic; 8. Secondary Prevention; 9. Valproic Acid [*therapeutic use]; | Provide MESH terms for the study
Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [adverse effects, *therapeutic use]; 2. Aripiprazole; 3. Benzodiazepines [adverse effects, therapeutic use]; 4. Molindone [adverse effects, therapeutic use]; 5. Olanzapine; 6. Piperazines [adverse effects, therapeutic use]; 7. Psychotic Disorders [*drug therapy]; 8. Quinolones [adverse effects, therapeutic use]; 9. Randomized Controlled Trials as Topic; 10. Risperidone [adverse effects, therapeutic use]; 11. Schizophrenia [drug therapy]; | Provide MESH terms for the study
Atypical antipsychotics for psychosis in adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. Depression [*therapy]; 2. Exercise [*psychology]; 3. Psychotherapy; 4. Randomized Controlled Trials as Topic; 5. Treatment Outcome; | Provide MESH terms for the study
Exercise for depression | You are a research assistant. Based on the question please provide appropriate answers |
1. *Safety; 2. Accidents, Traffic [*prevention & control]; 3. Automobile Driver Examination [*psychology]; 4. Dementia [*psychology]; 5. Transportation; | Provide MESH terms for the study
Driving assessment for maintaining mobility and safety in drivers with dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Alzheimer Disease [*rehabilitation]; 2. Cognitive Behavioral Therapy [*methods]; 3. Dementia, Vascular [*rehabilitation]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Hydrocephalus, Normal Pressure [*surgery]; 2. Pressure; 3. Ventriculoperitoneal Shunt [*instrumentation, methods]; | Provide MESH terms for the study
Flow‐regulated versus differential pressure‐regulated shunt valves for adult patients with normal pressure hydrocephalus | You are a research assistant. Based on the question please provide appropriate answers |
1. Cholinesterase Inhibitors [*therapeutic use]; 2. Dementia, Vascular [*drug therapy]; 3. Nootropic Agents [*therapeutic use]; 4. Phenylcarbamates [*therapeutic use]; 5. Rivastigmine; | Provide MESH terms for the study
Rivastigmine for vascular cognitive impairment | You are a research assistant. Based on the question please provide appropriate answers |
1. Antipsychotic Agents [adverse effects, *therapeutic use]; 2. Dibenzothiazepines [adverse effects, *therapeutic use]; 3. Patient Dropouts [statistics & numerical data]; 4. Quetiapine Fumarate; 5. Randomized Controlled Trials as Topic; 6. Schizophrenia [*drug therapy]; | Provide MESH terms for the study
Quetiapine versus typical antipsychotic medications for schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Bilirubin; 2. Family; 3. *Jaundice, Neonatal; 4. Phototherapy; | Provide MESH terms for the study
Intermittent phototherapy versus continuous phototherapy for neonatal jaundice | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchopulmonary Dysplasia [etiology, *prevention & control]; 2. Infant, Premature; 3. Intermittent Positive‐Pressure Ventilation [*methods, mortality]; 4. Pressure; 5. Randomized Controlled Trials as Topic; 6. Tidal Volume; | Provide MESH terms for the study
Volume‐targeted versus pressure‐limited ventilation in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Device Removal; 2. *Infant, Very Low Birth Weight; 3. *Umbilical Veins; 4. Catheter‐Related Infections [epidemiology, *prevention & control]; 5. Catheterization, Peripheral; 6. Catheters [*adverse effects]; 7. Cause of Death; 8. Central Venous Catheters; 9. Thrombosis [etiology]; 10. Time Factors; | Provide MESH terms for the study
Early planned removal of umbilical venous catheters to prevent infection in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Extremely Premature; 2. *Oxygen Consumption; 3. *Spectroscopy, Near‐Infrared; 4. Brain [*metabolism]; 5. Brain Injuries [*prevention & control]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Cerebral near‐infrared spectroscopy monitoring for prevention of brain injury in very preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchodilator Agents [therapeutic use]; 2. Cause of Death; 3. Hypertension, Pulmonary [*drug therapy, mortality]; 4. Nitric Oxide [therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Sildenafil Citrate [*therapeutic use]; 7. Vasodilator Agents [*therapeutic use]; | Provide MESH terms for the study
Sildenafil for pulmonary hypertension in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Phototherapy [methods, statistics & numerical data]; 2. Administration, Intravenous; 3. Administration, Oral; 4. Bilirubin [blood]; 5. Breast Feeding [statistics & numerical data]; 6. Cerebral Palsy [prevention & control]; 7. Exchange Transfusion, Whole Blood [statistics & numerical data]; 8. Fluid Therapy [*adverse effects, methods]; 9. Hyperbilirubinemia, Neonatal [blood, *therapy]; 10. Kernicterus [*prevention & control]; 11. Peristalsis; 12. Time Factors; | Provide MESH terms for the study
Fluid supplementation for neonatal unconjugated hyperbilirubinaemia | You are a research assistant. Based on the question please provide appropriate answers |
1. Extravasation of Diagnostic and Therapeutic Materials [*therapy]; 2. Hyaluronoglucosaminidase [*therapeutic use]; 3. Medical Records; 4. Skin [*injuries]; 5. Sodium Chloride [*therapeutic use]; 6. Solutions; 7. Therapeutic Irrigation [methods]; | Provide MESH terms for the study
Saline irrigation for the management of skin extravasation injury in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Amniotic Fluid; 2. Amikacin [therapeutic use]; 3. Ampicillin [therapeutic use]; 4. Anti‐Bacterial Agents [*therapeutic use]; 5. Bacterial Infections [*drug therapy, mortality, prevention & control]; 6. Gentamicins [therapeutic use]; 7. Incidence; 8. Length of Stay; 9. Meconium [*microbiology]; 10. Meconium Aspiration Syndrome [*drug therapy, epidemiology]; 11. Neonatal Sepsis [*drug therapy, mortality, prevention & control]; 12. Randomized Controlled Trials as Topic; 13. Respiration, Artificial [statistics & numerical data]; 14. Respiratory Insufficiency [epidemiology]; | Provide MESH terms for the study
Antibiotics for neonates born through meconium‐stained amniotic fluid | You are a research assistant. Based on the question please provide appropriate answers |
1. Gestational Age; 2. Infant, Premature; 3. Intensive Care Units, Neonatal [statistics & numerical data]; 4. Intubation, Intratracheal [instrumentation, *methods, statistics & numerical data]; 5. Pediatrics [statistics & numerical data]; | Provide MESH terms for the study
Orotracheal intubation in infants performed with a stylet versus without a stylet | You are a research assistant. Based on the question please provide appropriate answers |
1. *Clonidine [administration & dosage, adverse effects]; 2. *Dexmedetomidine [administration & dosage, adverse effects]; 3. *Hypnotics and Sedatives [administration & dosage, adverse effects]; 4. *Respiration, Artificial; 5. Cause of Death; 6. Hospital Mortality; 7. Intensive Care Units, Neonatal [statistics & numerical data]; 8. Length of Stay [statistics & numerical data]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Clonidine for sedation and analgesia for neonates receiving mechanical ventilation | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant Mortality; 2. *Infant, Extremely Premature; 3. Age Factors; 4. Arteries; 5. Blindness [epidemiology, etiology]; 6. Cerebral Palsy [epidemiology]; 7. Enterocolitis, Necrotizing [epidemiology, etiology]; 8. Incidence; 9. Oximetry; 10. Oxygen [*administration & dosage, adverse effects, *blood]; 11. Publication Bias; 12. Randomized Controlled Trials as Topic; 13. Retinopathy of Prematurity [epidemiology, etiology, prevention & control]; 14. Selection Bias; 15. Software; | Provide MESH terms for the study
Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cerebral Ventricles; 2. *Punctures [adverse effects]; 3. *Spinal Puncture [adverse effects]; 4. Cerebral Hemorrhage [complications, mortality, *therapy]; 5. Conservative Treatment [adverse effects]; 6. Controlled Clinical Trials as Topic; 7. Hydrocephalus [etiology, *prevention & control]; 8. Infant, Premature; 9. Non‐Randomized Controlled Trials as Topic; 10. Randomized Controlled Trials as Topic; 11. Retreatment; 12. Ventriculoperitoneal Shunt [adverse effects]; | Provide MESH terms for the study
Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage | You are a research assistant. Based on the question please provide appropriate answers |
1. Ankyloglossia [*surgery]; 2. *Breast Feeding [adverse effects]; 3. Gestational Age; 4. Lingual Frenum [*surgery]; 5. Mastodynia [etiology]; 6. Nipples; 7. Pain Measurement; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Frenotomy for tongue‐tie in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Developing Countries; 2. *Infant Mortality; 3. *Morbidity; 4. Randomized Controlled Trials as Topic; 5. Vitamin A [*administration & dosage, adverse effects]; 6. Vitamin A Deficiency [prevention & control]; 7. Vitamins [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Feeding; 2. Heart Rate [physiology]; 3. Hydrocortisone [analysis]; 4. Infant, Premature; 5. Injections, Intramuscular [*adverse effects]; 6. Kangaroo‐Mother Care Method [*methods]; 7. Oxygen Consumption [physiology]; 8. Pain Management [*methods]; 9. Phlebotomy [*adverse effects]; 10. Punctures [*adverse effects]; 11. Randomized Controlled Trials as Topic; 12. Saliva [chemistry]; 13. Term Birth; | Provide MESH terms for the study
Skin‐to‐skin care for procedural pain in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Anesthesia, Local [adverse effects, methods]; 2. Anesthetics, Local [*administration & dosage, adverse effects]; 3. Catheterization [adverse effects]; 4. Drug Combinations; 5. Infant, Premature; 6. Needles; 7. Pain [etiology, *prevention & control]; 8. Pain Measurement; 9. Phlebotomy [adverse effects]; 10. Punctures [*adverse effects]; 11. Randomized Controlled Trials as Topic; 12. Spinal Puncture [adverse effects]; 13. Tetracaine [*administration & dosage]; | Provide MESH terms for the study
Topical anaesthesia for needle‐related pain in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Hypnotics and Sedatives [*administration & dosage, adverse effects]; 2. Infant, Premature; 3. Infusions, Intravenous; 4. Intensive Care Units, Neonatal; 5. Intensive Care, Neonatal; 6. Length of Stay; 7. Midazolam [*administration & dosage, adverse effects]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit | You are a research assistant. Based on the question please provide appropriate answers |
1. Chronic Disease; 2. Clinical Trials as Topic; 3. Cromolyn Sodium [*therapeutic use]; 4. Infant, Premature; 5. Infant, Premature, Diseases [mortality, *prevention & control]; 6. Lung Diseases [mortality, *prevention & control]; 7. Meta‐Analysis as Topic; 8. Respiratory System Agents [*therapeutic use]; | Provide MESH terms for the study
Cromolyn sodium for the prevention of chronic lung disease in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Apnea [*therapy]; 2. Bradycardia [therapy]; 3. Infant, Premature; 4. Infant, Premature, Diseases [*therapy]; 5. Oxygen Consumption; 6. Patient Positioning [*methods]; 7. Posture [physiology]; 8. Randomized Controlled Trials as Topic; 9. Respiration; | Provide MESH terms for the study
Body positioning for spontaneously breathing preterm infants with apnoea | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Extracorporeal Membrane Oxygenation; 3. Hernia, Diaphragmatic [complications]; 4. High-Frequency Ventilation; 5. Nitric Oxide [administration & dosage, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Respiratory Insufficiency [*drug therapy, mortality]; 8. Term Birth; 9. Vasodilator Agents [administration & dosage, *therapeutic use]; | Provide MESH terms for the study
Nitric oxide for respiratory failure in infants born at or near term | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Very Low Birth Weight; 2. *Respiration, Artificial; 3. Administration, Inhalation; 4. Anti‐Inflammatory Agents [administration & dosage, *therapeutic use]; 5. Chronic Disease; 6. Glucocorticoids [administration & dosage, *therapeutic use]; 7. Infant, Premature; 8. Infant, Premature, Diseases [mortality, *prevention & control]; 9. Lung Diseases [mortality, *prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Steroids [administration & dosage]; 12. Time Factors; | Provide MESH terms for the study
Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Bronchopulmonary Dysplasia [mortality, prevention & control]; 3. Cerebral Hemorrhage [epidemiology, prevention & control]; 4. Incidence; 5. Infant, Premature; 6. Infant, Premature, Diseases [prevention & control, *therapy]; 7. Nitric Oxide [*administration & dosage]; 8. Randomized Controlled Trials as Topic; 9. Respiratory Insufficiency [*therapy]; 10. Salvage Therapy; 11. Vasodilator Agents [*administration & dosage]; | Provide MESH terms for the study
Inhaled nitric oxide for respiratory failure in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*therapeutic use]; 2. Heparin [*therapeutic use]; 3. Heparin, Low‐Molecular‐Weight [therapeutic use]; 4. Thrombosis [*drug therapy]; | Provide MESH terms for the study
Heparin for the treatment of thrombosis in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Oxygen [metabolism]; 2. Patient Positioning [*methods]; 3. Prone Position; 4. Randomized Controlled Trials as Topic; 5. Respiration, Artificial [*methods]; 6. Supine Position; | Provide MESH terms for the study
Infant position in neonates receiving mechanical ventilation | You are a research assistant. Based on the question please provide appropriate answers |
1. High-Frequency Ventilation [methods]; 2. Inhalation [physiology]; 3. Positive-Pressure Respiration [methods]; 4. Randomized Controlled Trials as Topic; 5. Respiration, Artificial [*methods]; | Provide MESH terms for the study
Synchronized mechanical ventilation for respiratory support in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Enteral Nutrition [*methods, standards]; 2. Hunger [*physiology]; 3. Infant Nutritional Physiological Phenomena [*physiology]; 4. Infant, Premature [*physiology]; 5. Randomized Controlled Trials as Topic; 6. Satiation [physiology]; 7. Time Factors; 8. Weight Gain; | Provide MESH terms for the study
Responsive versus scheduled feeding for preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cooking and Eating Utensils; 2. Bottle Feeding; 3. Breast Feeding; 4. Enteral Nutrition [instrumentation, *methods]; 5. Infant, Premature; 6. Length of Stay; | Provide MESH terms for the study
Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed | You are a research assistant. Based on the question please provide appropriate answers |
1. *Breast Feeding [statistics & numerical data]; 2. *Dietary Supplements [adverse effects]; 3. Dietary Carbohydrates [administration & dosage, adverse effects]; 4. Drinking Water [administration & dosage, adverse effects]; 5. Glucose [administration & dosage]; 6. Infant Food [*adverse effects]; 7. Randomized Controlled Trials as Topic; 8. Term Birth; 9. Time Factors; | Provide MESH terms for the study
Early additional food and fluids for healthy breastfed full‐term infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bottle Feeding; 2. *Breast Feeding; 3. *Infant, Premature; 4. *Sucking Behavior; 5. Hospitalization; 6. Time Factors; | Provide MESH terms for the study
Instruments for assessing readiness to commence suck feeds in preterm infants: effects on time to establish full oral feeding and duration of hospitalisation | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Analgesics [*administration & dosage]; 3. Infant, Premature; 4. Pain [physiopathology, *prevention & control]; 5. Pain Measurement; 6. Punctures [adverse effects]; 7. Randomized Controlled Trials as Topic; 8. Sucrose [*administration & dosage]; | Provide MESH terms for the study
Sucrose for analgesia in newborn infants undergoing painful procedures | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Agonists [*therapeutic use]; 2. Epinephrine [*therapeutic use]; 3. Oxygen Inhalation Therapy [statistics & numerical data]; 4. Randomized Controlled Trials as Topic; 5. Respiration, Artificial [statistics & numerical data]; 6. Transient Tachypnea of the Newborn [*drug therapy]; | Provide MESH terms for the study
Epinephrine for transient tachypnea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cerebral Ventricles; 2. *Infant, Very Low Birth Weight; 3. Anticoagulants [*therapeutic use]; 4. Cerebral Hemorrhage [mortality, *prevention & control]; 5. Heparin [*therapeutic use]; 6. Infant, Premature; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Heparin for the prevention of intraventricular haemorrhage in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Beds; 2. *Twins; 3. Child Development [*physiology]; 4. Infant Care [*methods]; 5. Infant, Premature [*growth & development]; 6. Intensive Care Units, Neonatal; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Co‐bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bandages [adverse effects]; 2. Alginates [therapeutic use]; 3. Anti‐Bacterial Agents [therapeutic use]; 4. Anti‐Infective Agents [*therapeutic use]; 5. Catheter‐Related Infections [*prevention & control]; 6. Catheterization, Central Venous [*adverse effects]; 7. Central Venous Catheters [*adverse effects]; 8. Chlorhexidine [therapeutic use]; 9. Dermatitis, Contact [etiology]; 10. Ethanol [therapeutic use]; 11. Glucuronic Acid [therapeutic use]; 12. Hexuronic Acids [therapeutic use]; 13. Polyurethanes; 14. Povidone‐Iodine [therapeutic use]; 15. Randomized Controlled Trials as Topic; 16. Silver Compounds [therapeutic use]; | Provide MESH terms for the study
Antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Extremely Premature; 2. Antithrombins [adverse effects, *therapeutic use]; 3. Cerebral Hemorrhage [mortality, *prevention & control]; 4. Cerebral Ventricles; 5. Infant, Premature, Diseases [mortality, *prevention & control]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Catheter Obstruction; 2. *Intubation, Intratracheal; 3. *Respiration, Artificial; 4. Infant, Low Birth Weight; 5. Lung [metabolism]; 6. Randomized Controlled Trials as Topic; 7. Suction [*methods]; 8. Time Factors; | Provide MESH terms for the study
Frequency of endotracheal suctioning for the prevention of respiratory morbidity in ventilated newborns | You are a research assistant. Based on the question please provide appropriate answers |
1. *Carbon Dioxide; 2. *Infant Mortality; 3. Blood Gas Monitoring, Transcutaneous [*methods]; 4. Morbidity; | Provide MESH terms for the study
Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchopulmonary Dysplasia [prevention & control]; 2. Emulsions; 3. Fatty Acids, Unsaturated; 4. Fish Oils [administration & dosage]; 5. gamma-Linolenic Acid [administration & dosage]; 6. *Infant, Premature; 7. Lipids [*administration & dosage]; 8. Olive Oil [administration & dosage]; 9. Parenteral Nutrition [*methods]; 10. Plant Oils [administration & dosage]; 11. Randomized Controlled Trials as Topic; 12. Retinopathy of Prematurity [prevention & control]; 13. Soybean Oil [*administration & dosage]; 14. Triglycerides [administration & dosage]; | Provide MESH terms for the study
Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Cesarean Section [adverse effects]; 3. Diuretics [administration & dosage, *therapeutic use]; 4. Furosemide [administration & dosage, *therapeutic use]; 5. Injections, Intravenous; 6. Oxygen Inhalation Therapy [statistics & numerical data]; 7. Randomized Controlled Trials as Topic; 8. Transient Tachypnea of the Newborn [*drug therapy]; | Provide MESH terms for the study
Diuretics for transient tachypnoea of the newborn | You are a research assistant. Based on the question please provide appropriate answers |
1. Ductus Arteriosus, Patent [*physiopathology]; 2. Infant, Extremely Premature; 3. Jaundice [*therapy]; 4. Phototherapy [*adverse effects]; 5. Radiation Protection [*methods]; 6. Randomized Controlled Trials as Topic; 7. Torso; | Provide MESH terms for the study
Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Infant Mortality; 2. *Intensive Care Units, Neonatal; 3. Patient Care Team [*organization & administration]; 4. *Specialization; 5. Transportation of Patients [*organization & administration]; | Provide MESH terms for the study
Specialist teams for neonatal transport to neonatal intensive care units for prevention of morbidity and mortality | You are a research assistant. Based on the question please provide appropriate answers |
1. *High‐Frequency Jet Ventilation; 2. *Infant, Premature; 3. *Infant, Very Low Birth Weight; 4. *Salvage Therapy; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial; 7. Respiratory Distress Syndrome, Newborn [*therapy]; | Provide MESH terms for the study
Rescue high‐frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Newborn; 2. Catheterization, Central Venous [adverse effects, *instrumentation]; 3. Catheterization, Peripheral [adverse effects, *instrumentation]; 4. Extravasation of Diagnostic and Therapeutic Materials [etiology]; 5. Infant, Extremely Low Birth Weight; 6. Infant, Premature; 7. Infant, Very Low Birth Weight; 8. Parenteral Nutrition [adverse effects, *instrumentation]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Central Venous Catheters; 2. Anti‐Infective Agents [*administration & dosage]; 3. Catheter‐Related Infections [*prevention & control]; 4. Silver Compounds [*administration & dosage]; 5. Umbilical Veins; 6. Zeolites [*administration & dosage]; | Provide MESH terms for the study
Antimicrobial‐impregnated central venous catheters for prevention of catheter‐related bloodstream infection in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant Mortality; 2. Decision Support Techniques; 3. Program Evaluation [*standards]; 4. Randomized Controlled Trials as Topic; 5. Resuscitation [*education, standards]; | Provide MESH terms for the study
Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Catheterization, Peripheral [*instrumentation]; 2. *Drug Contamination; 3. Filtration [*instrumentation]; 4. Infant Mortality; 5. Infant, Premature; 6. Infusions, Intravenous [adverse effects, *instrumentation]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intravenous in‐line filters for preventing morbidity and mortality in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Anesthesia, Conduction; 2. *Anesthesia, General; 3. Anesthesia, Epidural; 4. Anesthesia, Spinal; 5. Apnea [prevention & control]; 6. Bradycardia [prevention & control]; 7. Hernia, Inguinal [*surgery]; 8. Herniorrhaphy [*methods]; 9. Infant, Premature; 10. Infant, Premature, Diseases [*surgery]; 11. Postoperative Complications [prevention & control]; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Premature; 2. Continuous Positive Airway Pressure [*methods]; 3. Device Removal [adverse effects, *methods]; 4. Humidifiers; 5. Noninvasive Ventilation [*methods]; 6. Ventilator Weaning [adverse effects, *methods]; | Provide MESH terms for the study
Strategies for the discontinuation of humidified high flow nasal cannula (HHFNC) in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *High‐Frequency Ventilation; 2. Chronic Disease; 3. Infant, Premature; 4. Infant, Premature, Diseases [*prevention & control]; 5. Lung Diseases [*prevention & control]; 6. Lung Injury [prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Respiration, Artificial; 9. Respiratory Distress Syndrome, Newborn [therapy]; | Provide MESH terms for the study
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Equipment Safety; 2. Infant, Premature; 3. Intensive Care, Neonatal [methods]; 4. Intubation, Intratracheal [adverse effects, *instrumentation, methods]; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [instrumentation, methods]; | Provide MESH terms for the study
Methods for securing endotracheal tubes in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Home Care Services; 2. *Hospitalization; 3. Gestational Age; 4. Jaundice, Neonatal [*therapy]; 5. Phototherapy [*methods]; 6. Term Birth; | Provide MESH terms for the study
Home‐ versus hospital‐based phototherapy for the treatment of non‐haemolytic jaundice in infants at more than 37 weeks' gestation | You are a research assistant. Based on the question please provide appropriate answers |
1. Bone Density [physiology]; 2. Bone Diseases, Metabolic [prevention & control]; 3. Calcification, Physiologic [*physiology]; 4. Infant, Premature [growth & development, *physiology]; 5. Motor Activity [*physiology]; 6. Musculoskeletal Manipulations [*methods]; 7. Randomized Controlled Trials as Topic; 8. Weight Gain [physiology]; | Provide MESH terms for the study
Physical activity programs for promoting bone mineralization and growth in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Very Low Birth Weight; 2. *Lighting [adverse effects]; 3. Eye Protective Devices; 4. Infant, Premature; 5. Light [*adverse effects]; 6. Randomized Controlled Trials as Topic; 7. Retinopathy of Prematurity [etiology, *prevention & control]; | Provide MESH terms for the study
Early light reduction for preventing retinopathy of prematurity in very low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchoalveolar Lavage [*methods]; 2. Meconium Aspiration Syndrome [mortality, *therapy]; 3. Pulmonary Surfactants [*therapeutic use]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Lung lavage for meconium aspiration syndrome in newborn infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Cyclooxygenase Inhibitors [*therapeutic use]; 2. Ductus Arteriosus, Patent [*drug therapy, *surgery]; 3. Indomethacin [therapeutic use]; 4. Infant, Premature; 5. Infant, Very Low Birth Weight; 6. Ligation; 7. Pneumothorax [etiology]; 8. Postoperative Complications; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Adaptation, Physiological; 2. Child Development [*physiology]; 3. Enteral Nutrition [adverse effects, *methods]; 4. Enterocolitis, Necrotizing [prevention & control]; 5. Infant Formula; 6. Infant, Premature; 7. Infant, Very Low Birth Weight [growth & development, *physiology]; 8. Milk; 9. Milk, Human; 10. Parenteral Nutrition [adverse effects, methods]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Hypotension [*drug therapy]; 2. Lypressin [analogs & derivatives, therapeutic use]; 3. Terlipressin; 4. Vasoconstrictor Agents [*therapeutic use]; 5. Vasopressins [*therapeutic use]; | Provide MESH terms for the study
Vasopressin and its analogues for the treatment of refractory hypotension in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Low Birth Weight; 2. *Infant, Premature; 3. Enteral Nutrition [*instrumentation, methods]; 4. Intubation, Gastrointestinal [*methods]; 5. Intubation, Intratracheal [*methods]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [therapeutic use]; 2. Hydralazine [*therapeutic use]; 3. Hypoxia [*drug therapy]; 4. Infant, Premature; 5. Respiratory Insufficiency [*drug therapy]; 6. Vasodilator Agents [*therapeutic use]; | Provide MESH terms for the study
Hydralazine in infants with persistent hypoxemic respiratory failure | You are a research assistant. Based on the question please provide appropriate answers |
1. Alemtuzumab [therapeutic use]; 2. Cladribine [therapeutic use]; 3. Daclizumab [therapeutic use]; 4. Dimethyl Fumarate [therapeutic use]; 5. Fingolimod Hydrochloride [therapeutic use]; 6. Glatiramer Acetate [therapeutic use]; 7. Immunologic Factors [therapeutic use]; 8. *Immunosuppressive Agents [therapeutic use]; 9. Interferon beta-1a [therapeutic use]; 10. Interferon beta-1b [therapeutic use]; 11. *Multiple Sclerosis, Relapsing-Remitting [drug therapy]; 12. Natalizumab [therapeutic use]; 13. Network Meta-Analysis; 14. Recurrence; | Provide MESH terms for the study
Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Adrenal Cortex Hormones [adverse effects]; 2. *Carpal Tunnel Syndrome [drug therapy]; 3. Hand; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Local corticosteroid injection versus placebo for carpal tunnel syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. *Amyotrophic Lateral Sclerosis [complications]; 2. *Botulinum Toxins, Type A [therapeutic use]; 3. Clinical Trials, Phase II as Topic; 4. *Deglutition Disorders [complications, etiology]; 5. Diarrhea [complications]; 6. *Motor Neuron Disease [complications]; 7. Nausea; 8. Randomized Controlled Trials as Topic; 9. Saliva; 10. Scopolamine Derivatives; 11. *Sialorrhea [drug therapy, etiology]; | Provide MESH terms for the study
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics [therapeutic use]; 2. *Chronic Pain [drug therapy]; 3. Clonidine [adverse effects]; 4. *Diabetic Neuropathies [drug therapy]; 5. *Neuralgia [drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Topical clonidine for neuropathic pain in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized; 2. Gadolinium [therapeutic use]; 3. Interferon beta-1a [adverse effects]; 4. *Multiple Sclerosis [drug therapy]; 5. *Multiple Sclerosis, Relapsing-Remitting [drug therapy]; 6. Recurrence; | Provide MESH terms for the study
Ocrelizumab for multiple sclerosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Immunoglobulins, Intravenous [therapeutic use]; 2. Plasma Exchange; 3. *Polyneuropathies [drug therapy]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Immunoglobulin for multifocal motor neuropathy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Azetidines; 2. Benzyl Compounds; 3. *Multiple Sclerosis [drug therapy]; 4. *Multiple Sclerosis, Chronic Progressive; | Provide MESH terms for the study
Siponimod for multiple sclerosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Fingolimod Hydrochloride; 2. Glatiramer Acetate; 3. *Multiple Sclerosis [drug therapy]; 4. *Multiple Sclerosis, Chronic Progressive [drug therapy]; 5. Rituximab [adverse effects]; | Provide MESH terms for the study
Rituximab for people with multiple sclerosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Activities of Daily Living; 2. Cognition; 3. Memory Disorders [etiology]; 4. *Multiple Sclerosis; 5. Quality of Life; | Provide MESH terms for the study
Memory rehabilitation for people with multiple sclerosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. *Exercise; 3. Health Promotion [*methods]; 4. Muscle Stretching Exercises; 5. Neuromuscular Diseases [*rehabilitation]; 6. Outcome Assessment, Health Care; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Resistance Training [statistics & numerical data]; 10. Time Factors; 11. Walking [statistics & numerical data]; | Provide MESH terms for the study
Interventions for promoting physical activity in people with neuromuscular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Double-Blind Method; 3. Exenatide [administration & dosage, adverse effects, *therapeutic use]; 4. Glucagon-Like Peptide-1 Receptor [*agonists]; 5. Hypoglycemic Agents [administration & dosage, therapeutic use]; 6. Parkinson Disease [*drug therapy]; 7. Placebos [administration & dosage]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Self Administration; 11. Single-Blind Method; | Provide MESH terms for the study
GLP‐1 receptor agonists for Parkinson's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal [therapeutic use]; 2. Antineoplastic Agents [*therapeutic use]; 3. Antineoplastic Agents, Immunological [therapeutic use]; 4. Brain Neoplasms [*drug therapy, mortality]; 5. Cancer Vaccines [therapeutic use]; 6. Disease Progression; 7. ErbB Receptors [*antagonists & inhibitors]; 8. Glioblastoma [*drug therapy, mortality]; 9. Lymphopenia [etiology]; 10. Neoplasm Recurrence, Local [drug therapy]; 11. Neutropenia [etiology]; 12. Protein Kinase Inhibitors [*therapeutic use]; 13. Protein-Tyrosine Kinases [antagonists & inhibitors]; 14. Randomized Controlled Trials as Topic; 15. Thrombocytopenia [etiology]; | Provide MESH terms for the study
Anti‐epidermal growth factor receptor therapy for glioblastoma in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cell‐ and Tissue‐Based Therapy; 2. Amyotrophic Lateral Sclerosis [complications, *therapy]; 3. Disease Progression; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; 6. Vital Capacity; | Provide MESH terms for the study
Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.